OTC Markets OTCQB - Delayed Quote USD

MustGrow Biologics Corp. (MGROF)

Compare
1.0400 0.0000 (0.00%)
As of October 21 at 4:00 PM EDT. Market Open.
Loading Chart for MGROF
DELL
  • Previous Close 1.0400
  • Open 1.0400
  • Bid 1.0500 x --
  • Ask 1.0800 x 40000
  • Day's Range 1.0400 - 1.0400
  • 52 Week Range 0.4060 - 1.1600
  • Volume 800
  • Avg. Volume 1,067
  • Market Cap (intraday) 53.706M
  • Beta (5Y Monthly) 1.66
  • PE Ratio (TTM)
  • EPS (TTM) 0.0000
  • Earnings Date Nov 27, 2024 - Dec 2, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

MustGrow Biologics Corp., an agricultural biotechnology company, focuses on development and commercialization of natural biological technologies and products from mustard seeds. It provides Biocontrol technology platform to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and others; treat unwanted plant growth for use in organic agriculture, and home and garden markets, as well as agriculture markets where glyphosate has been banned; and suppress sprouting, and treat disease and pathogen for storage and food preservation markets. The company also offers TerraMG, a mustard-derived soil biopesticide technology. In addition, it is developing TerraSante, an organic soil amendment and biofertility technology. The company was formerly known as Duport Capital Ltd. and changed its name to MustGrow Biologics Corp. in March 2018. MustGrow Biologics Corp. was incorporated in 2014 and is headquartered in Saskatoon, Canada.

mustgrow.ca

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: MGROF

View More

Performance Overview: MGROF

Trailing total returns as of 10/22/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

MGROF
7.22%
S&P/TSX Composite index
17.67%

1-Year Return

MGROF
59.02%
S&P/TSX Composite index
29.01%

3-Year Return

MGROF
70.65%
S&P/TSX Composite index
16.26%

5-Year Return

MGROF
112.24%
S&P/TSX Composite index
45.07%

Compare To: MGROF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MGROF

View More

Valuation Measures

Annual
As of 10/21/2024
  • Market Cap

    54.63M

  • Enterprise Value

    51.62M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    16.09

  • Price/Book (mrq)

    20.57

  • Enterprise Value/Revenue

    15.12

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -9.00%

  • Return on Assets (ttm)

    1.20%

  • Return on Equity (ttm)

    -12.23%

  • Revenue (ttm)

    4.71M

  • Net Income Avi to Common (ttm)

    -423.95k

  • Diluted EPS (ttm)

    0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    4.67M

  • Total Debt/Equity (mrq)

    13.83%

  • Levered Free Cash Flow (ttm)

    741.52k

Research Analysis: MGROF

View More

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 4.71M
Earnings 3.43M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Company Insights: MGROF

People Also Watch